The global Mingmu Dihuang Pills market size is predicted to grow from US$ 54.1 million in 2025 to US$ 69.5 million in 2031; it is expected to grow at a CAGR of 4.3% from 2025 to 2031.

Mingmu   Dihuang Pills is a Chinese patent medicine formulated according to   traditional Chinese medicine theory. It is mainly used to treat eye diseases   caused by liver and kidney yin deficiency, such as vision loss, dry eyes,   tearing in the wind, blurred vision and other symptoms. The medicine combines   a variety of natural herbal ingredients that have the effects of nourishing   the liver and kidney, nourishing blood and improving eyesight. Among them,   Rehmannia glutinosa is the main medicinal material, supplemented by   wolfberry, chrysanthemum, cornus officinalis, peony bark, etc. It regulates   the balance of yin and yang in the human body, enhances the function of the   liver and kidneys, promotes blood circulation in the eyes, relieves eye   fatigue, and improves vision.

United States market for Mingmu Dihuang Pills is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Mingmu Dihuang Pills is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Mingmu Dihuang Pills is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Mingmu Dihuang Pills players cover Taizhou Nanfeng Pharmaceutical Co., Ltd., Harbin Pharmaceutical Group Shiyitang Pharmaceutical Factory, Jiangxi Jiuhua Pharmaceutical Co., Ltd., Inner Mongolia Jiujun Pharmaceutical Co., Ltd., Henan Shizhen Pharmaceutical Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Mingmu Dihuang Pills Industry Forecast” looks at past sales and reviews total world Mingmu Dihuang Pills sales in 2024, providing a comprehensive analysis by region and market sector of projected Mingmu Dihuang Pills sales for 2025 through 2031. With Mingmu Dihuang Pills sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mingmu Dihuang Pills industry.

This Insight Report provides a comprehensive analysis of the global Mingmu Dihuang Pills landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Mingmu Dihuang Pills portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Mingmu Dihuang Pills market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mingmu Dihuang Pills and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mingmu Dihuang Pills.

This report presents a comprehensive overview, market shares, and growth opportunities of Mingmu Dihuang Pills market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    Water-honey Pills
    Large Honey Pills

Segmentation by Application:

    Hospital
    Clinic
    Other

This report also splits the market by region:

    Americas

        United States
        Canada
        Mexico
        Brazil

    APAC

        China
        Japan
        Korea
        Southeast Asia
        India
        Australia

    Europe

        Germany
        France
        UK
        Italy
        Russia

    Middle East & Africa

        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

    Taizhou Nanfeng Pharmaceutical Co., Ltd.
    Harbin Pharmaceutical Group Shiyitang Pharmaceutical Factory
    Jiangxi Jiuhua Pharmaceutical Co., Ltd.
    Inner Mongolia Jiujun Pharmaceutical Co., Ltd.
    Henan Shizhen Pharmaceutical Co., Ltd.
    Jiangxi Guoyao Co., Ltd.
    Liaoning Chaohua Pharmaceutical Co., Ltd.
    Jiangxi Minji Pharmaceutical Co., Ltd.
    Yaodu Pharmaceutical Group Co., Ltd.
    Jiangsu Yihai Pharmaceutical Co., Ltd.
    Liaoning Dongyi Pharmaceutical Co., Ltd.
    Lanzhou Foci Pharmaceutical Co., Ltd.
    Guangdong Taiantang Pharmaceutical Co., Ltd.
    Jilin Jinbao Pharmaceutical Co., Ltd.
    Zhejiang Tianyitang Pharmaceutical Co., Ltd.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Mingmu Dihuang Pills market?
What factors are driving Mingmu Dihuang Pills market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Mingmu Dihuang Pills market opportunities vary by end market size?
How does Mingmu Dihuang Pills break out by Type, by Application?